Novo sends oral Wegovy into China’s GLP-1 race
Novo has sent oral Wegovy into China’s GLP-1 market race behind Lilly.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Novo has sent oral Wegovy into China’s GLP-1 market race behind Lilly.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.